UroGen Pharma Receives FDA Approval for ZUSDURI for Recurrent Bladder Cancer
UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts.
Urogen Pharma Ltd. (URGN)
Market is closed
News
- 1 - 10
- Next >>
11 Best Hot Stocks to Buy According to Wall Street Analysts
On July 1, Ralph Schlosstein, Evercore's chairman emeritus and BlackRock's co-founder, joined 'Closing Bell Overtime' on CNBC to talk about his outlook for markets heading into the second half of the ...
H.C. Wainwright Sees Billion Dollar Potential in UroGen’s New Therapy
UroGen Pharma Ltd. (NASDAQ:URGN) is among the best NASDAQ stocks under $50 to buy. On Monday, analysts at H.C. Wainwright significantly raised the rating for UroGen Pharma Ltd.
10 Best NASDAQ Stocks Under $50 to Buy
In this era where everyone is striving for the best, whether it be something in daily life or technology, the stock market is no exception.
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2025 Earnings Call Transcript
Operator: Hello and welcome to UroGen Pharma First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the UroGen Pharma Fourth Quarter and Full Year 2024 Earnings Call.
10 Best Small-Cap Growth Stocks to Buy Now
On November 4, 2024, Nick Sheridan, Portfolio Manager at Janus Henderson released a report on small-cap stocks exploring how these stocks offer unique growth and diversification opportunities.
UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by and welcome to the UroGen Pharma Third Quarter 2024 Earnings Call. Please be advised that today's conference is being recorded.
10 Worst Middle East and Africa Stocks To Buy According to Short Sellers
According to the IMF's Middle East and North Africa Economic Update from April 2024, the MENA region is expected to see moderate growth of 2.7% in 2024, up from 1.9% in 2023.
- 1 - 10
- Next >>
Billionaire Hedge Funds
